Press releases

Release issued 6th June 2006

York, UK, 24 May 2006—Following the recent re-launch of the Deals and alliances therapy reports, Phamalicensing announces another revised set of reports from the Partneringdesk series in quick succession—the Deals Briefing reports.

Each Deals Briefing report focuses on a top pharmaceutical company, conveniently providing an overview of the deal and alliances announced in the last five years. The report also includes company profile information, consolidated financial data, deal statistics, deal summaries and detailed deal descriptions.

"The Partneringdesk team is continually working on improving and diversifying its range of products to aid biopharmaceutical companies worldwide large or small, in search for potential partners or are interested in deal making activity," said Suzanne Elvidge, Head of Publishing. "Every deal entry includes a detailed deal description and financial information where disclosed, such as headline values, upfront and milestone payments."

For more information on Partneringdesk Deals Briefings or other products, go to http://pharmalicensing.com/desk, or contact the Partneringdesk team on tel: +44 1904 520460 or email: partneringdesk@pharmalicensing.com.

(20th October 2011) Bridgehead International Appoints Expert in Global Pricing and Market Access for Oncology Products

(20th October 2011) Bridgehead International announces publication by The Personalized Medicine Coalition (PMC) of a white paper entitled “Advancing Access to Personalized Medicine: A Comparative Assessment

(13th September 2011) Bridgehead International Appoints Marcus Deans as Principal Consultant

(1st August 2011) Bridgehead International Announces US West Coast Expansion

(14th June 2011) Bridgehead International appoints Nigel Seear as Vice President, Europe